We are analyzing https://link.springer.com/article/10.1007/s007020070034.

Title:
Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3β inhibition and in neurons | Journal of Neural Transmission
Description:
Muscarinic agonists alter the metabolism of amyloid precursor protein, leading to an increase in α-secretase cleavage and a decreased production of amyloidogenic peptides; suggesting that these compounds might modify the Alzheimer
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Telecommunications
Social Networks

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

article, tau, muscarinic, phosphorylation, privacy, cookies, content, journal, agonists, gskβ, access, information, publish, search, alzheimers, data, log, research, neural, nonneuronal, cells, inhibition, neurons, forlenza, spink, dayanandan, disease, kinase, receptor, discover, springer, optional, personal, parties, policy, find, track, transmission, reduce, cite, anderton, olesen, lovestone, explore, metabolism, protein, compounds, process, impairment, glycogen,

Topics {✒️}

month download article/chapter reduced tau phosphorylation gsk-3β phosphorylation gsk-3β inhibition neural transmission aims ampk ameliorates alzheimer privacy choices/manage cookies muscarinic agonists alter full article pdf related subjects stably phosphorylated tau m1 receptor disease-modifying properties specific muscarinic agonist tau phosphorylation european economic area scope submit manuscript α-secretase cleavage early event correlating microtubule-binding properties muscarinic receptor conditions privacy policy glycogen synthase kinase-3 amyloid precursor protein accepting optional cookies gsk-3β journal finder publish neuronal cells expressing pkcε activation article journal cognitive impairment article log neural transm 107 article forlenza article cite 1007/s007020070034 keywords phosphorylates tau disease process check access instant access privacy policy personal data lovestone department books a muscarinic receptors tau pathology protein kinase optional cookies manage preferences journal publish

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3β inhibition and in neurons
         description: Muscarinic agonists alter the metabolism of amyloid precursor protein, leading to an increase in α-secretase cleavage and a decreased production of amyloidogenic peptides; suggesting that these compounds might modify the Alzheimer's disease process. A second therapeutic target in AD is the accumulation of stably phosphorylated tau into neurofibrillary tangles; an early event correlating with cognitive impairment. Glycogen synthase kinase-3 (GSK-3β) phosphorylates tau and is inhibited via protein kinase C (PKC). As certain muscarinic receptors are linked to PKC, we examined the effect of a range of agonists on GSK-3β phosphorylation of tau. In neurons a non-specific muscarinic agonist, carbachol, reduced tau phosphorylation. In non-neuronal cells expressing the m1 receptor a range of m1 agonists reduced transiently-expressed tau phosphorylation and altered its microtubule-binding properties. These findings link the two pathological process of AD – APP metabolism and tau phosphorylation – and suggest that muscarinic and other cholinergic compounds might have disease-modifying properties.
         datePublished:
         dateModified:
         pageStart:1201
         pageEnd:1212
         sameAs:https://doi.org/10.1007/s007020070034
         keywords:
            Keywords: Tau, muscarinic receptor, acetylcholine, Alzheimer's disease, glycogen synthase kinase-3.
            Neurology
            Psychiatry
            Neurosciences
         image:
         isPartOf:
            name:Journal of Neural Transmission
            issn:
               1435-1463
               0300-9564
            volumeNumber:107
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:O. V. Forlenza
               affiliation:
                     name:Laboratory of Neuroscience (LIM-27), Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Brazil
                     address:
                        name:Laboratory of Neuroscience (LIM-27), Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Brazil, , BR
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. M. Spink
               affiliation:
                     name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
                     address:
                        name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Dayanandan
               affiliation:
                     name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
                     address:
                        name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
                        type:PostalAddress
                     type:Organization
               type:Person
               name:B. H. Anderton
               affiliation:
                     name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
                     address:
                        name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
                        type:PostalAddress
                     type:Organization
               type:Person
               name:O. F. Olesen
               affiliation:
                     name:Department of Neurobiology, H. Lundbeck A/S, Copenhagen-Valby, Denmark
                     address:
                        name:Department of Neurobiology, H. Lundbeck A/S, Copenhagen-Valby, Denmark, , DK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Lovestone
               affiliation:
                     name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
                     address:
                        name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3β inhibition and in neurons
      description: Muscarinic agonists alter the metabolism of amyloid precursor protein, leading to an increase in α-secretase cleavage and a decreased production of amyloidogenic peptides; suggesting that these compounds might modify the Alzheimer's disease process. A second therapeutic target in AD is the accumulation of stably phosphorylated tau into neurofibrillary tangles; an early event correlating with cognitive impairment. Glycogen synthase kinase-3 (GSK-3β) phosphorylates tau and is inhibited via protein kinase C (PKC). As certain muscarinic receptors are linked to PKC, we examined the effect of a range of agonists on GSK-3β phosphorylation of tau. In neurons a non-specific muscarinic agonist, carbachol, reduced tau phosphorylation. In non-neuronal cells expressing the m1 receptor a range of m1 agonists reduced transiently-expressed tau phosphorylation and altered its microtubule-binding properties. These findings link the two pathological process of AD – APP metabolism and tau phosphorylation – and suggest that muscarinic and other cholinergic compounds might have disease-modifying properties.
      datePublished:
      dateModified:
      pageStart:1201
      pageEnd:1212
      sameAs:https://doi.org/10.1007/s007020070034
      keywords:
         Keywords: Tau, muscarinic receptor, acetylcholine, Alzheimer's disease, glycogen synthase kinase-3.
         Neurology
         Psychiatry
         Neurosciences
      image:
      isPartOf:
         name:Journal of Neural Transmission
         issn:
            1435-1463
            0300-9564
         volumeNumber:107
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:O. V. Forlenza
            affiliation:
                  name:Laboratory of Neuroscience (LIM-27), Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Brazil
                  address:
                     name:Laboratory of Neuroscience (LIM-27), Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Brazil, , BR
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. M. Spink
            affiliation:
                  name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
                  address:
                     name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Dayanandan
            affiliation:
                  name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
                  address:
                     name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
                     type:PostalAddress
                  type:Organization
            type:Person
            name:B. H. Anderton
            affiliation:
                  name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
                  address:
                     name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
                     type:PostalAddress
                  type:Organization
            type:Person
            name:O. F. Olesen
            affiliation:
                  name:Department of Neurobiology, H. Lundbeck A/S, Copenhagen-Valby, Denmark
                  address:
                     name:Department of Neurobiology, H. Lundbeck A/S, Copenhagen-Valby, Denmark, , DK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Lovestone
            affiliation:
                  name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
                  address:
                     name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neural Transmission
      issn:
         1435-1463
         0300-9564
      volumeNumber:107
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Laboratory of Neuroscience (LIM-27), Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Brazil
      address:
         name:Laboratory of Neuroscience (LIM-27), Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Brazil, , BR
         type:PostalAddress
      name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
      address:
         name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
         type:PostalAddress
      name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
      address:
         name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
         type:PostalAddress
      name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
      address:
         name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
         type:PostalAddress
      name:Department of Neurobiology, H. Lundbeck A/S, Copenhagen-Valby, Denmark
      address:
         name:Department of Neurobiology, H. Lundbeck A/S, Copenhagen-Valby, Denmark, , DK
         type:PostalAddress
      name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
      address:
         name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:O. V. Forlenza
      affiliation:
            name:Laboratory of Neuroscience (LIM-27), Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Brazil
            address:
               name:Laboratory of Neuroscience (LIM-27), Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Brazil, , BR
               type:PostalAddress
            type:Organization
      name:J. M. Spink
      affiliation:
            name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
            address:
               name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
               type:PostalAddress
            type:Organization
      name:R. Dayanandan
      affiliation:
            name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
            address:
               name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
               type:PostalAddress
            type:Organization
      name:B. H. Anderton
      affiliation:
            name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
            address:
               name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
               type:PostalAddress
            type:Organization
      name:O. F. Olesen
      affiliation:
            name:Department of Neurobiology, H. Lundbeck A/S, Copenhagen-Valby, Denmark
            address:
               name:Department of Neurobiology, H. Lundbeck A/S, Copenhagen-Valby, Denmark, , DK
               type:PostalAddress
            type:Organization
      name:S. Lovestone
      affiliation:
            name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom
            address:
               name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Laboratory of Neuroscience (LIM-27), Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Brazil, , BR
      name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
      name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
      name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
      name:Department of Neurobiology, H. Lundbeck A/S, Copenhagen-Valby, Denmark, , DK
      name:Department of Neuroscience, Institute of Psychiatry, London, United Kingdom, , GB
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(35)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

3.9s.

LINK . SPRINGER . COM {}